pharma prices price change drug price tender management government tenders government tendering drug price comparison reference pricing strategy reference price price performance

Complete the form
below to watch

this webinar

Gilead & Model N Webinar: Improve Effectiveness in Global, Regional & Market pricing

A Recent European survey indicated that 87% of responding life Sciences companies see External reference pricing as key to competitive advantage but only 12% have adequate technology, processes and teams in place to gain competitive advantage.

Listen to Mark Hill from Gilead and James Robinson from Model N zoom in on some key best practices for successful launch sequencing and building a business case for a global pricing improvement program.

Model N